The Impact of Plecanatide on Patient-Reported Assessments of Disease Severity, Quality of Life, and Treatment Satisfaction in Adults With Irritable Bowel Syndrome With Constipation

Sustained Improvements in Fatigue and Quality of Life in Patients with Iron Deficiency Anemia Due to Gastrointestinal Disorders Following a Single Course
of Ferumoxytol

 Hepatitis C Positive Donor to Hepatitis C Negative Recipient
Transplant Program

 Effects of Ferric Carboxymaltose vs Ferumoxytol on Hypophosphatemia inPatients with Iron Deficiency Anemia due to Gastrointestinal Disorders

Triple E (Engagement, Education and Eradication) for Individuals with Chronic Hepatitis C: > 2 Years of Results of a Successful, Collaborative, US Model for Improving Education, Screening and

Linkage to Care in an
Underserved Population

 Plecanatide Significantly Reduces Global Symptoms, Abdominal Pain, and Bloating in Individuals With Irritable Bowel Syndrome With Constipation Experiencing Varying Levels of Abdominal Pain and
Bloating at Baseline

A novel score to evaluate abdominal symptom improvement in patients with constipation-predominant

irritable bowel syndrome demonstrates efficacy of linaclotide for improving abdominal bloating,

discomfort, and pain in a Phase 3b trial

A Giant Lipoma:
Rare Cause of Colo-colonic Intussusception in an Adult

 Safety and Efficacy at 48 Weeks After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Chronic HBV Patients With Risk Factors for TDF Use